Clifford A. Hudis

Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: feasibility and efficacy.

T J Yao, C. Hudis, L. Norton, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.

T. Cornelison, N. Sneige, S. Lippman, 2015, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer.

J. Baselga, V. Semiglazov, A. Manikhas, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.